JAGX
Price
$2.01
Change
-$0.02 (-0.99%)
Updated
Sep 23 closing price
Capitalization
4.37M
NCNA
Price
$3.89
Change
-$0.12 (-2.99%)
Updated
Sep 23 closing price
Capitalization
7.42M
Interact to see
Advertisement

JAGX vs NCNA

Header iconJAGX vs NCNA Comparison
Open Charts JAGX vs NCNABanner chart's image
Jaguar Health
Price$2.01
Change-$0.02 (-0.99%)
Volume$92.16K
Capitalization4.37M
NuCana
Price$3.89
Change-$0.12 (-2.99%)
Volume$240.63K
Capitalization7.42M
JAGX vs NCNA Comparison Chart in %
Loading...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JAGX vs. NCNA commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAGX is a Hold and NCNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (JAGX: $2.01 vs. NCNA: $3.89)
Brand notoriety: JAGX and NCNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAGX: 82% vs. NCNA: 34%
Market capitalization -- JAGX: $4.37M vs. NCNA: $7.42M
JAGX [@Biotechnology] is valued at $4.37M. NCNA’s [@Biotechnology] market capitalization is $7.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAGX’s FA Score shows that 1 FA rating(s) are green whileNCNA’s FA Score has 1 green FA rating(s).

  • JAGX’s FA Score: 1 green, 4 red.
  • NCNA’s FA Score: 1 green, 4 red.
According to our system of comparison, both JAGX and NCNA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAGX’s TA Score shows that 4 TA indicator(s) are bullish while NCNA’s TA Score has 4 bullish TA indicator(s).

  • JAGX’s TA Score: 4 bullish, 4 bearish.
  • NCNA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both JAGX and NCNA are a good buy in the short-term.

Price Growth

JAGX (@Biotechnology) experienced а +2.03% price change this week, while NCNA (@Biotechnology) price change was -11.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NCNA($7.42M) has a higher market cap than JAGX($4.37M). JAGX YTD gains are higher at: -92.040 vs. NCNA (-98.366). NCNA has higher annual earnings (EBITDA): -20.4M vs. JAGX (-38.75M). NCNA has more cash in the bank: 8.44M vs. JAGX (2.21M). NCNA has less debt than JAGX: NCNA (154K) vs JAGX (30.5M). JAGX has higher revenues than NCNA: JAGX (11.8M) vs NCNA (0).
JAGXNCNAJAGX / NCNA
Capitalization4.37M7.42M59%
EBITDA-38.75M-20.4M190%
Gain YTD-92.040-98.36694%
P/E Ratio0.05N/A-
Revenue11.8M0-
Total Cash2.21M8.44M26%
Total Debt30.5M154K19,805%
FUNDAMENTALS RATINGS
JAGX vs NCNA: Fundamental Ratings
JAGX
NCNA
OUTLOOK RATING
1..100
519
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6566
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
1450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JAGX's Valuation (12) in the Pharmaceuticals Generic industry is in the same range as NCNA (12) in the Biotechnology industry. This means that JAGX’s stock grew similarly to NCNA’s over the last 12 months.

JAGX's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as NCNA (100) in the Biotechnology industry. This means that JAGX’s stock grew similarly to NCNA’s over the last 12 months.

JAGX's SMR Rating (100) in the Pharmaceuticals Generic industry is in the same range as NCNA (100) in the Biotechnology industry. This means that JAGX’s stock grew similarly to NCNA’s over the last 12 months.

JAGX's Price Growth Rating (65) in the Pharmaceuticals Generic industry is in the same range as NCNA (66) in the Biotechnology industry. This means that JAGX’s stock grew similarly to NCNA’s over the last 12 months.

JAGX's P/E Growth Rating (99) in the Pharmaceuticals Generic industry is in the same range as NCNA (100) in the Biotechnology industry. This means that JAGX’s stock grew similarly to NCNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JAGXNCNA
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 5 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCH30.610.88
+2.96%
Banco de ChileAmerican
ZIMV18.900.02
+0.11%
ZimVie
FFBC25.82-0.20
-0.77%
First Financial Bancorp
CAPS1.30-0.03
-2.26%
Capstone Holding Corp
LIDR2.52-0.12
-4.55%
AEye

JAGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAGX has been closely correlated with CDTX. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if JAGX jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
-0.99%
CDTX - JAGX
90%
Closely correlated
-2.62%
NCNA - JAGX
89%
Closely correlated
-2.99%
TAOX - JAGX
89%
Closely correlated
-2.90%
RNAC - JAGX
89%
Closely correlated
-2.29%
NBY - JAGX
88%
Closely correlated
+1.42%
More

NCNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with CDTX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
-2.99%
CDTX - NCNA
93%
Closely correlated
-2.62%
NBY - NCNA
92%
Closely correlated
+1.42%
RNAC - NCNA
92%
Closely correlated
-2.29%
TAOX - NCNA
92%
Closely correlated
-2.90%
AGEN - NCNA
92%
Closely correlated
-3.48%
More